Position in VTRS
as of Mar 31, 2026
· filed Apr 27, 2026
Position Value
$829,445
-$43,522 QoQ
Shares Held
61,395
-12.4% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2020
22 quarters on record
Voting authority
Sole 37.10888508836224.ToString("F0")%
Shared 4.857073051551429.ToString("F0")%
None 58.034041860086326.ToString("F0")%
Common Shares in VTRS Over Time
Shares Held
Position Value (USD)
Derivatives in VTRS
reported options exposure · as of Dec 31, 2022CallValue
$311,640
CallShares
28,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026TRUIST FINANCIAL CORP holds $44,449,493 across 15 Drug Manufacturers - Specialty & Generic names. VTRS ranks #8 (1.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
108,852 | $12,867,394 | |
| 2 | TEVA |
Teva Pharmaceutical Industries Ltd
|
426,240 | $12,838,348 | |
| 3 | HLN |
Haleon plc
|
498,893 | $4,993,918 | |
| 4 | ELAN |
Elanco Animal Health Inc
|
162,747 | $3,894,534 | |
| 5 | UTHR |
UNITED THERAPEUTICS Corp
|
5,679 | $3,367,532 | |
| 6 | NBIX |
Neurocrine Biosciences Inc
|
11,168 | $1,471,271 | |
| 7 | TAK |
Takeda Pharmaceutical Co Ltd
|
69,832 | $1,293,286 | |
| 8 | VTRS |
Viatris Inc
This page
|
61,395 | $829,445 |
All Filings in VTRS
Export CSV
27 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $829,445 | 61,395 | Shares | Defined | 2026-04-27 | |
| 2025-12-31 | $872,967 | 70,118 | Shares | Defined | 2026-02-02 | |
| 2025-09-30 | $925,343 | 93,469 | Shares | Defined | 2025-11-03 | |
| 2025-06-30 | $970,404 | 108,668 | Shares | Defined | 2025-07-18 | |
| 2025-03-31 | $951,348 | 109,225 | Shares | Defined | 2025-04-29 | |
| 2024-12-31 | $1,453,001 | 116,707 | Shares | Defined | 2025-01-31 | |
| 2024-09-30 | $1,498,525 | 129,072 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $2,823,581 | 265,624 | Shares | Defined | 2024-08-21 | |
| 2024-03-31 | $3,503,528 | 293,428 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $2,651,420 | 244,822 | Shares | Defined | 2024-02-02 | |
| 2023-09-30 | $1,689,697 | 171,369 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $1,771,797 | 177,535 | Shares | Defined | 2023-08-01 | |
| 2023-03-31 | $1,909,183 | 198,460 | Shares | Defined | 2023-05-05 | |
| 2022-12-31 | $2,242,882 | 201,517 | Shares | Defined | 2023-02-17 | |
| 2022-12-31 | $311,640 | 28,000 | Call | Defined | 2023-02-17 | |
| 2022-09-30 | $1,529,150 | 179,478 | Shares | Defined | 2022-10-26 | |
| 2022-09-30 | $238,560 | 28,000 | Call | Defined | 2022-10-26 | |
| 2022-06-30 | $293,160 | 28,000 | Call | Defined | 2022-07-22 | |
| 2022-06-30 | $2,846,571 | 271,879 | Shares | Defined | 2022-07-22 | |
| 2022-03-31 | $304,640 | 28,000 | Call | Defined | 2022-04-22 | |
| 2022-03-31 | $3,457,238 | 317,761 | Shares | Defined | 2022-04-22 | |
| 2021-12-31 | $6,587,729 | 486,898 | Shares | Defined | 2022-02-14 | |
| 2021-12-31 | $378,840 | 28,000 | Call | Defined | 2022-02-14 | |
| 2021-09-30 | $8,428,816 | 622,053 | Shares | Defined | 2021-11-05 | |
| 2021-06-30 | $9,370,379 | 655,730 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $9,898,107 | 708,526 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $10,837,958 | 578,333 | Shares | Defined | 2021-11-19 | |
| No filing history on record for this holder in this stock. | ||||||